Tarek El Moussa FINALLY Opens Up About Divorce

If you’re a fan of the HGTV show Flip or Flop, then you’ve likely heard by now that hosts Tarek and Christina El Moussa are getting divorced . The split made tabloid headlines, not only because the El Moussas appeared to have the perfect marriage, but also because of the ugly confrontation that led to their decision to part ways.

Pitt researchers uncover genetic marker that may predict drug response in many cancer types

Researchers at the University of Pittsburgh School of Medicine have uncovered a novel genetic mechanism of thyroid cancer, as well as a marker that may predict response to a particular class of drugs, not just in patients with thyroid cancer, but in those with many other types of cancer as well. The new findings were published in Proceedings of the National Academy of Sciences .

Many people are unaware of thyroid conditions

Despite it effecting millions of Americans, more than half of the people living with a thyroid condition aren’t aware of the issue, a situation that can contribute to chronic health problems, including weight gain and infertility. “A thyroid condition is very, very common,” says Dr. Sherry Zhou, endocrinologist with Mosaic Life Care.

Brothers receive cancer diagnosis 11 months apart,a

Dealing with one child diagnoses with cancer can be a traumatic blow for any family, but what if 11 months later, another one of your children is also diagnosed? Brison Ricker, 15, was diagnosed with DIPG on Jan. 22, 2016. This is one of the the deadliest forms of childhood cancers.

Forget Gilead Sciences Inc.: These 2 Stocks Doubled Last Year

Despite a generally bleak year for Gilead, and for biotech stocks in general, shares of Exelixis, Inc. Can these biotechs continue climbing throughout the new year and beyond, or are they about to sputter and run out of fuel? Let’s look at what’s propelling them upward to see why they might be better picks than Gilead Sciences. A string of good news for Exelixis’ lead cancer drug made this one of the best-performing biotech stocks of 2016.